Skip to main navigation Skip to search Skip to main content

Tilsotolimod with ipilimumab drives tumor responses in anti–pd-1 refractory melanoma

  • Cara Haymaker
  • , Daniel H. Johnson
  • , Ravi Murthy
  • , Salah Eddine Bentebibel
  • , Marc I. Uemura
  • , Courtney W. Hudgens
  • , Houssein Safa
  • , Marihella James
  • , Robert H.I. Andtbacka
  • , Douglas B. Johnson
  • , Montaser Shaheen
  • , Michael A. Davies
  • , Shah Rahimian
  • , Srinivas K. Chunduru
  • , Denái R. Milton
  • , Michael T. Tetzlaff
  • , Willem W. Overwijk
  • , Patrick Hwu
  • , Nashat Gabrail
  • , Sudhir Agrawal
  • Gary Doolittle, Igor Puzanov, Joseph Markowitz, Chantale Bernatchez, Adi Diab

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tilsotolimod with ipilimumab drives tumor responses in anti–pd-1 refractory melanoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry